Description
Description
Retatrutide (100mg) is a bulk research-grade triple agonist. It is designed for comprehensive metabolic studies requiring high-purity triple pathway modulation.
Research Applications
Utilized for systemic endocrine research and energy balance investigations in preclinical models.
Reviews
There are no reviews yet.